日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The landscape of conventional and artificial intelligence-based clinical prediction models in non-small-cell lung cancer: from development to real-world validation

非小细胞肺癌传统临床预测模型与人工智能临床预测模型的现状:从研发到真实世界验证

Howard, H R; Hasanova, M; Tiwari, A; Ghose, A; Winayak, R; Nahar, T; Chauhan, V; Arun, S; Palmer, K; Houston, A; Kumar, N S; Lalwani, S; Januszewski, A; Conibear, J; Jain, A; Cortellini, A; Passaro, A; Addeo, A; Noronha, V; Banna, G L; Boussios, S

The risk of lung cancer from vaping or e-cigarette usage: a systematic review

电子烟或吸食电子烟与肺癌风险:一项系统性综述

Mohapatra, S; Tiwari, A; Kandala, A; Winayak, R; Ghose, A; Das, R; Hasanova, M; Gunani, M; Jaswal, G; Mitra, S; Noronha, V; Jain, A; Merletti, F; Passaro, A; Cortellini, A; Addeo, A; Banna, G L; Boussios, S

Ideas for mentorship in oncology for medical students and early career doctors: insights from a UK-wide oncology mentorship scheme

为医学生和青年医生提供肿瘤学导师指导的思路:来自英国全国肿瘤学导师指导计划的启示

Kucharczak, Joanna; Khoury, Emma G; Toiber Kent, Yarden; Winayak, Rahul; Duke, Simon

Spotlight on Lung Cancer Disparities in India

聚焦印度肺癌差异

Gunani, Manas; Winayak, Rahul; Agarwal, Anisha; Ghose, Aruni; Das, Rounak; Prabhash, Kumar; Noronha, Vanita; Banna, Giuseppe Luigi; Boussios, Stergios; Mitra, Swarupa

Nilotinib Versus Imatinib in Philadelphia Chromosome-Positive Chronic Myeloid Leukemia (Ph+ CML): A Systematic Review and Meta-Analysis of Randomized Controlled Trials (RCTs)

尼洛替尼与伊马替尼治疗费城染色体阳性慢性粒细胞白血病(Ph+ CML):随机对照试验(RCT)的系统评价和荟萃分析

Zafar, Fabeha; Poombal, Fnu; Ashraf, Laraib; Shivakumar, Divya; Wankhade, Diptish; Winayak, Rahul; Ali Malik, Ghulam Mustafa; Mahapatra, Shruti Sagar; G C, Shasan; Huynh, Truc; Mylavarapu, Maneeth